How is low-dose interleukin-2 (IL-2) therapy for kidney cancer given?

Low-dose interleukin-2 (IL-2) treatment for kidney cancer patients involves the following:
  • Therapy will consist of low-dose subcutaneous injections (shot under the skin) of IL-2 given once daily Monday through Friday for six weeks.
  • The dose of IL-2 during the first week of therapy will be higher than the following five weeks.
  • This therapy will be given on an outpatient basis.
  • Patients will be evaluated for response to therapy two to four weeks after completion of one course of therapy.
  • Additional courses of therapy may be offered dependent upon patient response and tolerance to treatment.

Continue Learning about Anti-HIV Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.